The synthesis and structural characterization of several lithium thiolates are reported. Formation of discrete species can be achieved by careful variation of ligand size and donor hapticity, as exemplified by the monomeric formulation of Li(PMDTA)STrityl (PMDTA = N, N, N ‘, N ‘‘, N ‘‘-pentamethyldiethylenetriamine, Trityl = CPh 3 ), 1, and Li(PMDTA)STrip, 2 (Trip = 2,4,6-iPr 3 C 6 H 2 ), versus the dimeric species [Li(THF) 2 STrityl] 2, 3, and [Li(TMEDA)STrip] 2, 4 (TMEDA = N, N, N ‘, N ‘-tetramethylethylenediamine). By control of the stoichiometry of the donor, the first trimeric lithium thiolate [Li(THF)SMes*] 3, 5 (Mes* = 2,4,6-tBu 3 C 6 H 2 ), exhibiting a six-membered ring system and rare three-coordinate lithium centers, becomes available. In contrast, use of a crown ether leads to the isolation of the monomeric contact ion pair Li(12-crown-4)STrityl, 6, while employing the cumbersome −SMes* ligand allows for the isolation of the first solvent-separated lithium thiolate [Li(12-crown-4) 2 ][SMes*], 7 . All compounds were prepared by reacting the respective thiols with nBuLi in the presence of various donor adjuncts. The target molecules were characterized using 1 H NMR and IR spectroscopy and melting point criteria. Crystal structure analysis was employed to determine solid state structures. Crystal data are as follows. 1: Cu Kα (λ = 1.541 78 Å) at 130 K, a = 12.152(3) Å, b = 15.260(3) Å, c = 14.764(5) Å, β = 106.90(2)°, V = 2619.6(12) Å 3, Z = 4, monoclinic, space group P 2 1 / c, 2526 reflections ( I > 2σ( I )), R = 0.064. 2: Cu Kα (λ = 1.541 78 Å) at 228 K, a = 15.805(7) Å, b = 9.206(4) Å, c = 18.923(7) Å, β = 99.74(3)°, V = 2714(2) Å 3, Z = 4, monoclinic, space group P 2 1 / n, 2047 reflections ( I > 2σ( I )), R = 0.085. 3: Mo Kα (λ = 0.710 73 Å) at 213 K, a = 13.141(3) Å, b = 12.381(2) Å, c = 14.664(3) Å, β = 94.84(3)°, V = 2377.3(8) Å 3, Z = 2, monoclinic, space group P 2 1 / n, 2622 reflections ( I > 2σ( I )), R = 0.052. 4: Cu Kα (λ = 1.541 78 Å) at 130 K, a = 18.906(4) Å, b = 9.516(2) Å, c = 25.617(5) Å, β = 92.75(3)°, V = 4603(2) Å 3, Z = 4, monoclinic, space group I 2/ a, 2390 reflections ( I > 2σ( I )), R = 0.067. 5: Mo Kα (λ = 0.710 73 Å) at 213 K, a = 9.991(2) Å, b = 17.934(4) Å, c = 20.314(4) Å, α = 83.36(3)°, β = 76.74(3)°, γ = 76.72(3)°, V = 3440.4(12) Å 3, Z = 2, triclinic, space group P 1, 6397 reflections ( I > 2.5σ( I )), R = 0.063. 6: Mo Kα (λ = 0.710 73 Å) at 213 K, a = 10.542(2) Å, b = 12.821(3) Å, c = 18.729(4) Å, β = 102.22(3)°, V = 2474.0(9) Å 3, Z = 4, monoclinic, space group P 2 1 / c, 4206 reflections ( I > 2σ( I )), R = 0.086. 7: Mo Kα (λ = 0.710 73 Å) at 213 K, a = 10.134(2) Å, b = 19.800(4) Å, c = 18.423(4) Å, β = 93.15(3)°, V = 3691.0(13) Å 3, Z = 4, monoclinic, space group P 2 1 / n, 4088 reflections ( I > 2σ( I )), R = 0.092.
No takes yet. Share an insight, caveat, or question.
Ruhlandt‐Senge et al. (1996) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: